Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 116, Issue 4, Pages 1045-1051Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI27083
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA085721, CA85721] Funding Source: Medline
- NIAID NIH HHS [R01 AI043407-10, R01 AI043407] Funding Source: Medline
Ask authors/readers for more resources
LIGHT is an important costimulatory molecule for T cell immunity. Recent studies have further implicated its role in innate immunity and inflammatory diseases, but its cellular and molecular mechanisms remain elusive. We report here that LIGHT is upregulated and functions as a proinflammatory cytokine in 2 independent experimental hepatitis models, induced by concanavalin A and Listeria monocytogenes. Molecular mutagenesis studies suggest that soluble LIGHT protein produced by cleavage from the cell membrane plays an important role in this effect through the interaction with the lymphotoxin-beta receptor (LT beta R) but not herpes virus entry mediator. NK1.1(+) T cells contribute to the production, but not the cleavage or effector functions, of soluble LIGHT. Importantly, treatment with a mAb that specifically interferes with the LIGHT-LT beta R interaction protects mice from lethal hepatitis. Our studies thus identify a what we believe to be a novel function of soluble LIGHT in vivo and offer a potential target for therapeutic interventions in hepatic inflammatory diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available